MOVE
Movano Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-2502.32
P/S
18.12
EV/EBITDA
-0.23
DCF Value
$0.01
FCF Yield
-243.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-424.9%
Operating Margin
-3580.4%
Net Margin
-6207.2%
ROE
35364.5%
ROA
-479.9%
ROIC
-1085.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $44.0K | $12.4M | $-20.60 |
| FY 2025 | $433.0K | $-18.3M | $-21.79 |
| Q3 2025 | $80.0K | $-4.0M | $-0.05 |
| Q2 2025 | $103.0K | $-3.2M | $-0.41 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.87
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.